Coexpression cluster:C763

Full id: C763_cord_B_splenic_xeroderma_b_hairy_mycosis

Phase1 CAGE Peaks

Hg19::chr17:48270438..48270450,-	p2@X98708
Hg19::chr19:6586908..6586931,-	p@chr19:6586908..6586931 -
Hg19::chr1:117605017..117605033,+	p@chr1:117605017..117605033 +
Hg19::chr1:12125156..12125160,+	p@chr1:12125156..12125160 +
Hg19::chr1:220393543..220393560,+	p@chr1:220393543..220393560 +
Hg19::chr1:56797895..56797912,-	p@chr1:56797895..56797912 -
Hg19::chr2:223288613..223288620,+	p13@SGPP2
Hg19::chr3:121797240..121797259,-	p@chr3:121797240..121797259 -
Hg19::chr3:16552074..16552079,+	p@chr3:16552074..16552079 +
Hg19::chr5:169173501..169173512,+	p@chr5:169173501..169173512 +
Hg19::chrX:53743451..53743487,-	p@chrX:53743451..53743487 -

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n
lymphocyte of B lineage	9.51e-41	24
pro-B cell	9.51e-41	24
lymphoid lineage restricted progenitor cell	1.95e-27	52
lymphocyte	6.78e-27	53
common lymphoid progenitor	6.78e-27	53
nucleate cell	7.14e-26	55
circulating cell	1.17e-19	6
antibody secreting cell	1.10e-13	1
plasma cell	1.10e-13	1
plasmablast	1.10e-13	1
hematopoietic cell	4.98e-12	177
nongranular leukocyte	1.43e-11	115
hematopoietic lineage restricted progenitor cell	4.89e-11	120
leukocyte	1.39e-09	136
hematopoietic oligopotent progenitor cell	7.00e-08	161
hematopoietic multipotent progenitor cell	7.00e-08	161
hematopoietic stem cell	1.71e-07	168
angioblastic mesenchymal cell	1.71e-07	168
mature B cell	1.75e-07	2
pre-B-II cell	1.75e-07	2
transitional stage B cell	1.75e-07	2
small pre-B-II cell	1.75e-07	2
immature B cell	1.75e-07	2

Uber Anatomy

Ontology term	p-value	n
umbilical cord	4.82e-12	10
blastocyst	4.82e-12	10
blastula	4.82e-12	10
bilaminar disc	4.82e-12	10
inner cell mass	4.82e-12	10
cleaving embryo	4.82e-12	10
connecting stalk	4.82e-12	10
inner cell mass derived epiblast	4.82e-12	10
extraembryonic mesoderm	4.82e-12	10
blood	3.30e-08	15
haemolymphatic fluid	3.30e-08	15
organism substance	3.30e-08	15

Disease

Ontology term	p-value	n
lymphoma	1.54e-30	10
genetic disease	8.58e-14	1
monogenic disease	8.58e-14	1
xeroderma pigmentosum	8.58e-14	1
non-Hodgkin lymphoma	9.73e-14	1
cutaneous T cell lymphoma	9.73e-14	1
mycosis fungoides	9.73e-14	1
anemia	2.07e-13	1
hematologic cancer	2.45e-08	51
immune system cancer	2.45e-08	51
hematopoietic system disease	2.40e-07	2

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF	#promoters	Enrichment	p-value	q-value
BCL11A#53335	4	10.3161654922207	0.000417002126339225	0.00392283237909767
EBF1#1879	9	7.28710923810191	1.25865967327101e-07	7.20686171144468e-06
MEF2A#4205	4	6.81572033077966	0.00197285899353115	0.0115852358968456
MEF2C#4208	3	11.2667330434429	0.00202141580025861	0.0117468642757183
NFKB1#4790	10	4.98914856744894	3.69910541950576e-07	1.82317541721455e-05
POLR2A#5430	11	2.14745317655807	0.000223198342238743	0.00248593491149323

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---

This analysis result is provided for C0 - C305 clusters.